MedTrace Logo

Evaluation of Vitamin D Levels in Psoriasis Patients

NCT01903317 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2024-05-08

No results posted yet for this study

Summary

The purpose of this research study is to find out more about the relationship between vitamin D and psoriasis.

Conditions

Interventions

OTHER

Topical Therapy

Subjects will continue use of topical therapy (e.g. topical corticosteroids, keratolytic agents, anthralin, coal tar, vitamin D analogs, retinoids) for their psoriasis as if they were not participating in this study.

OTHER

Phototherapy and Systemic Therapy

Subjects will continue use of phototherapy (e.g. ultraviolet B \[UVB\] or ultraviolet A and psoralen \[PUVA\]) and systemic therapy (e.g. methotrexate, cyclosporine) for their psoriasis as if they were not participating in this study.

OTHER

Biologic Therapy

Subjects will continue use of biologic therapy (e.g. etanercept, adalimumab, ustekinumab) for their psoriasis as if they were not participating in this study.

Sponsors & Collaborators

  • University of California, Irvine

    lead OTHER

Principal Investigators

  • Jennifer Soung, M.D. · University of California, Irvine

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-06-30
Primary Completion
2015-07-31
Completion
2015-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01903317 on ClinicalTrials.gov